Associations of Polymorphisms in MTHFR Gene with the Risk of Age-Related Cataract in Chinese Han Population: A Genotype-Phenotype Analysis

• Published in: PloS one 2015-12, Vol.10 (12), p.e0145581-e0145581
• Main Authors: Wang, Xue-bin, Qiao, Chen, Wei, Li, Han, Ya-di, Cui, Ning-hua, Huang, Zhu-liang, Li, Zu-hua, Zheng, Fang, Yan, Ming
• Format: Article
• Language: English
• Subjects: Age; Aged; Aged, 80 and over; Aging - genetics; Alleles; Asian Continental Ancestry Group - genetics; Binding sites; Care and treatment; Case-Control Studies; Cataract - genetics; Cataracts; Cortex; Deoxyribonucleic acid; Disease; DNA; Endoplasmic reticulum; Enzymatic activity; Enzyme activity; Enzyme-linked immunosorbent assay; Enzymes; Female; Folic acid; Gene expression; Genetic Predisposition to Disease; Genomes; Genotypes; Glaucoma; Haplotypes; Homocysteine; Homocysteine - blood; Humans; Immunoassays; Male; Metabolism; Methylenetetrahydrofolate reductase; Methylenetetrahydrofolate Reductase (NADPH2) - blood; Methylenetetrahydrofolate Reductase (NADPH2) - genetics; Middle Aged; Oxidative stress; Patients; Physiological aspects; Plasma; Polymorphism; Polymorphism, Single Nucleotide; Risk factors; Single nucleotide polymorphisms; Single-nucleotide polymorphism; Statistical analysis; Transcription factors; Vitamin B; Vitamin B 12 - blood; Vitamin B 6 - blood; Vitamin B12; Vitamin B6; Vitamins; Wang, Chen; Welded joints
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0145581

Homocysteine (Hcy) is a potential risk factor for age-related cataract (ARC). Methylenetetrahydrofolate reductase (MTHFR) is the key enzyme for Hcy metabolism, and variants of MTHFR may affect MTHFR enzyme activity. This study mainly evaluated the associations between variants in MTHFR gene, plasma MTHFR enzyme activity, total Hcy (tHcy) levels and ARC risk in Chinese population. Four single nucleotide polymorphisms (SNPs) in MTHFR gene were genotyped using the high-resolution melting (HRM) method in 502 ARC patients (mean age, 70.2 [SD, 9.0], 46.0% male) and 890 healthy controls (mean age, 67.1 [SD, 11.1], 47.6% male). The plasma MTHFR activity, folic acid (FA), vitamins B12 and B6 levels were detected by enzyme-linked immunosorbent assays (ELISA). The plasma tHcy levels were measured by an automated enzymatic assay. After the Bonferroni correction, the minor allele T of SNP rs1801133 showed a significant association with an increased risk of overall ARC (OR = 1.26, P = 0.003). Consistent association was also found between SNP rs1801133 and cortical ARC risk (OR = 1.44, P = 0.003). Haplotype analyses revealed an adverse effect of the haplotype "C-A-T-C" (alleles in order of SNPs rs3737967, rs1801131, rs1801133 and rs9651118) on ARC risk (OR = 1.55, P = 0.003). Moreover, in a joint analysis of SNPs rs9651118 and rs1801133, subjects with two unfavorable genotypes had a 1.76-fold increased risk of ARC compared with the reference group, and a statistically significant dose-response trend (Ptrend = 0.001) was also observed. Further, in healthy controls and patients with cortical ARC, the allele T of SNP rs1801133 and the increasing number of unfavorable genotypes were significantly correlated with decreased MTHFR activity as well as increased tHcy levels. However, there was no significant association between FA, vitamins B12, B6 levels and MTHFR variants. Our data indicated that variants in MTHFR gene might individually and jointly influence susceptibility to ARC by affecting MTHFR enzyme activity and tHcy levels.